B-cell acute lymphoblastic leukemia (B-ALL) is the most common cancer in children, accounting for around 85% of pediatric ...

By Nick Rothschild Click here for updates on this story FOUNTAIN, Colorado (KMGH) — As a junior at Fountain-Fort Carson High ...

Nancy Delia knows cancer treatment saved her life after she was diagnosed with acute lymphoblastic leukemia (Ph+). But while ...

Fifty-two cancer survivors and their families came together in the East Valley to celebrate the strength and resilience of pediatric cancer patients.

Despite failing to achieve MRD-negativity after induction, patients with Ph+ acute lymphoblastic leukemia treated with ...

When Miranda Aldridge first noticed a tiny bump near her daughter Cameron’s eye, it didn’t seem alarming, just unusual. But ...

Concurrent acute myeloid leukemia and chronic lymphocytic leukemia: A review and clinical insights. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include ...

Ibrahim Aldoss, MD, associate professor, City of Hope, explores recent findings on ponatinib as a first-line treatment for Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL).

Persistent racial disparities in AML survival in the FLT3 inhibitor era. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text component.

A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, ...